Aesculapius

Brescia, Italy Founded: 1959 • Age: 67 yrs Acquired By Ceres Pharma
Pharmaceutical products, food supplements, and cosmetics are developed and sold.

About Aesculapius

Aesculapius is a Healthcare company based in Brescia (Italy) founded in 1959, and was acquired by Ceres Pharma in January 2024. Pharmaceutical products, food supplements, and cosmetics are developed and sold. Its focus areas include Traditional Pharmaceuticals. Its legal entity is ÆSCULAPIUS Farmaceutici S.r.l.

Company details

Aesculapius was established in 1959 in Brescia, Italy, within the pharmaceutical sector. A variety of products is developed and distributed, encompassing medicines with original active ingredients and formulations, food supplements, cosmetics, and medical devices. Operations focus on innovation and compliance in the healthcare industry, serving markets through established supply chains in Europe.

  • Headquarters Brescia, Italy
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    ••••••••
  • Phone
    •••• ••••
  • Website aesculapius.it
  • Social LinkedIn Facebook
  • Acquired by Ceres Pharma (Jan 2024)
  • Legal Name Æsculapius Farmaceutici S.R.L.
Key Metrics

Investors in Aesculapius

Aesculapius has secured backing from 1 investor. Prominent investors backing the company include Ceres Pharma.

All
InvestorDescriptionFounded YearDomainLocation
Nutritional supplements are manufactured and marketed by Ceres Pharma.
2017ceres-pharma.comMerelbeke, Belgium
Premium access

Investor details for Aesculapius

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Aesculapius

1 people are tracked at Aesculapius (1 in leadership).

NameRoleGroup
Enzo Moroni
Managing DirectorLeadership
Premium access

Complete people profiles for Aesculapius

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Aesculapius

2 dated milestones of Aesculapius across 65 years, from founding to its latest funding, stage changes and deals.

  1. Founded Aesculapius is founded.
  2. Exit Acquired by Ceres Pharma.

Web traffic of Aesculapius

The website of Aesculapius (aesculapius.it) receives about 3.2K visits a month.

  • Monthly visits
    3.2K

    ▲ 0.7% vs previous month

Similar websites

Websites whose visitors overlap most with Aesculapius. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
effeverde.it
effeverde.it
100%
#752,788–
laboratorioasclepio.com
laboratorioasclepio.com
100%
–
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Aesculapius

Aesculapius was founded in 1959.

Aesculapius is headquartered in Brescia, Italy. It is registered at Brescia, Lombardy, Italy.

Aesculapius was established in 1959 in Brescia, Italy, within the pharmaceutical sector. A variety of products is developed and distributed, encompassing medicines with original active ingredients and formulations, food supplements, cosmetics, and medical devices. Operations focus on innovation and compliance in the healthcare industry, serving markets through established supply chains in Europe.

Aesculapius has 1 investor. Key investors include Ceres Pharma.

Aesculapius operates through Æsculapius Farmaceutici S.R.L..

Yes. Aesculapius was acquired by Ceres Pharma in January 2024.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available